Sanofi has released its Q2 2026 aide-mémoire document on its investor website to assist financial modeling for the upcoming quarterly results. This memo includes details on non-comparable items, currency impacts, and share count. The full Q2 2026 earnings report will be published on July 30, 2026. Sanofi continues to focus on innovation in biopharma and AI to drive long-term growth and improve global health outcomes.
Banco Santander maintains a fair valuation at 1.37 times book value, but its 2.3% dividend yield offers limited income appeal. The bank's diversified operations remain resilient, though challenges in Brazil's margins and credit pressures impacted Q3 ...
Pomerantz LLP is investigating Banco Santander and some of its officers for potential securities fraud following the bank's Q3 2026 results, which showed a revenue miss of €370 million and a 2% drop in net profit. The results were impacted by integra...
